Leandro F. Vendruscolo

Leandro F. Vendruscolo

Auto-generated profile, based on publicly available information

Leandro F. Vendruscolo

Stress and Addiction Neuroscience Unit, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, and National Institute on Alcohol Abuse and Alcoholism, Division of Intramural Clinical and Biological Research, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
VCVicky Chuong
Vicky Chuong
Mehdi FarokhniaMehdi Farokhnia
Mehdi Farokhnia
SKSophia Khom
Sophia Khom
CPClaire L. Pince
Claire L. Pince
SESophie K. Elvig
Sophie K. Elvig
LLLorenzo Leggio
Lorenzo Leggio
Growing evidence indicates that the glucagon-like peptide-1 (GLP-1) system is involved in the neurobiology of addictive behaviors, and GLP-1 analogues may be used for the treatment of alcohol use disorder (AUD). Here, we examined the effects of semaglutide, a long-acting GLP-1 analogue, on biobehavioral correlates of alcohol use in rodents. A drinking-in-the-dark procedure was used to test the effects of semaglutide on binge-like drinking in male and female mice. We also tested the effects of semaglutide on binge-like and dependence-induced alcohol drinking in male and female rats, as well as acute effects of semaglutide on spontaneous inhibitory postsynaptic currents (sIPSCs) from central amygdala (CeA) and infralimbic cortex (ILC) neurons. Semaglutide dose-dependently reduced binge-like alcohol drinking in mice; a similar effect was observed on the intake of other caloric/noncaloric solutions. Semaglutide also reduced binge-like and dependence-induced alcohol drinking in rats. Semaglutide increased sIPSC frequency in CeA and ILC neurons from alcohol-naive rats, suggesting enhanced GABA release, but had no overall effect on GABA transmission in alcohol-dependent rats. In conclusion, the GLP-1 analogue semaglutide decreased alcohol intake across different drinking models and species and modulated central GABA neurotransmission, providing support for clinical testing of semaglutide as a potentially novel pharmacotherapy for AUD.

29 June 2015 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
LVLeandro F. Vendruscolo
Leandro F. Vendruscolo
DEDavid Estey
David Estey
VGVivian Goodell
Vivian Goodell
LMLauren G. Macshane
Lauren G. Macshane
MLMarian L. Logrip
Marian L. Logrip
BMBarbara J. Mason
Barbara J. Mason
Alcoholism, or alcohol use disorder, is a major public health concern that is a considerable risk factor for morbidity and disability; therefore, effective treatments are urgently needed. Here, we demonstrated that the glucocorticoid receptor (GR) antagonist mifepristone reduces alcohol intake in alcohol-dependent rats but not in nondependent animals. Both systemic delivery and direct administration into the central nucleus of the amygdala, a critical stress-related brain region, were sufficient to reduce alcohol consumption in dependent animals. We also tested the use of mifepristone in 56 alcohol-dependent human subjects as part of a double-blind clinical and laboratory-based study. Relative to placebo, individuals who received mifepristone (600 mg daily taken orally for 1 week) exhibited a substantial reduction in alcohol-cued craving in the laboratory, and naturalistic measures revealed reduced alcohol consumption during the 1-week treatment phase and 1-week post-treatment phase in mifepristone-treated individuals. Mifepristone was well tolerated and improved liver-function markers. Together, these results support further exploration of GR antagonism via mifepristone as a therapeutic strategy for alcoholism.

1 January 2017 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
BPBrittany M. Priddy
Brittany M. Priddy
SCStephanie A. Carmack
Stephanie A. Carmack
LTLisa C. Thomas
Lisa C. Thomas
JVJanaina C.M. Vendruscolo
Janaina C.M. Vendruscolo
GKGeorge F. Koob
George F. Koob
LVLeandro F. Vendruscolo
Leandro F. Vendruscolo

15 April 2015 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
EBEstelle Barbier
Estelle Barbier
JTJenica D. Tapocik
Jenica D. Tapocik
NJNathan Juergens
Nathan Juergens
CPCaleb Pitcairn
Caleb Pitcairn
ABAbbey Borich
Abbey Borich
MHMarkus Heilig
Markus Heilig
Recent studies have suggested an association between alcoholism and DNA methylation, a mechanism that can mediate long-lasting changes in gene transcription. Here, we examined the contribution of DNA methylation to the long-term behavioral and molecular changes induced by a history of alcohol dependence. In search of mechanisms underlying persistent rather than acute dependence-induced neuroadaptations, we studied the role of DNA methylation regulating medial prefrontal cortex (mPFC) gene expression and alcohol-related behaviors in rats 3 weeks into abstinence following alcohol dependence. Postdependent rats showed escalated alcohol intake, which was associated with increased DNA methylation as well as decreased expression of genes encoding synaptic proteins involved in neurotransmitter release in the mPFC. Infusion of the DNA methyltransferase inhibitor RG108 prevented both escalation of alcohol consumption and dependence-induced downregulation of 4 of the 7 transcripts modified in postdependent rats. Specifically, RG108 treatment directly reversed both downregulation of synaptotagmin 2 (Syt2) gene expression and hypermethylation on CpG#5 of its first exon. Lentiviral inhibition ofSyt2expression in the mPFC increased aversion-resistant alcohol drinking, supporting a mechanistic role ofSyt2in compulsive-like behavior. Our findings identified a functional role of DNA methylation in alcohol dependence-like behavioral phenotypes and a candidate gene network that may mediate its effects. Together, these data provide novel evidence for DNA methyltransferases as potential therapeutic targets in alcoholism.

7 September 2016 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
GGGiordano De Guglielmo
Giordano De Guglielmo
ECElena Crawford
Elena Crawford
SKSarah Kim
Sarah Kim
LVLeandro F. Vendruscolo
Leandro F. Vendruscolo
BHBruce T. Hope
Bruce T. Hope
OGOlivier George
Olivier George
Abstinence from alcohol is associated with the recruitment of neurons in the central nucleus of the amygdala (CeA) in nondependent rats that binge drink alcohol and in alcohol-dependent rats. However, whether the recruitment of this neuronal ensemble in the CeA is causally related to excessive alcohol drinking or if it represents a consequence of excessive drinking remains unknown. We tested the hypothesis that the recruitment of a neuronal ensemble in the CeA during abstinence is required for excessive alcohol drinking in nondependent rats that binge drink alcohol and in alcohol-dependent rats. We found that inactivation of the CeA neuronal ensemble during abstinence significantly decreased alcohol drinking in both groups. In nondependent rats, the decrease in alcohol intake was transient and returned to normal the day after the injection. In dependent rats, inactivation of the neuronal ensemble with Daun02 produced a long-term decrease in alcohol drinking. Moreover, we observed a significant reduction of somatic withdrawal signs in dependent animals that were injected with Daun02 in the CeA. These results indicate that the recruitment of a neuronal ensemble in the CeA during abstinence from alcohol is causally related to excessive alcohol drinking in alcohol-dependent rats, whereas a similar neuronal ensemble only partially contributed to alcohol-binge-like drinking in nondependent rats. These results identify a critical neurobiological mechanism that may be required for the transition to alcohol dependence, suggesting that focusing on the neuronal ensemble in the CeA may lead to a better understanding of the etiology of alcohol use disorders and improve medication development.SIGNIFICANCE STATEMENTAlcohol dependence recruits neurons in the central nucleus of the amygdala (CeA). Here, we found that inactivation of a specific dependence-induced neuronal ensemble in the CeA reversed excessive alcohol drinking and somatic signs of alcohol dependence in rats. These results identify a critical neurobiological mechanism that is required for alcohol dependence, suggesting that targeting dependence neuronal ensembles may lead to a better understanding of the etiology of alcohol use disorders, with implications for diagnosis, prevention, and treatment.

23 February 2021 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
SESophie K. Elvig
Sophie K. Elvig
MMM. Adrienne McGinn
M. Adrienne McGinn
CSCaroline Smith
Caroline Smith
MAMichael A. Arends
Michael A. Arends
GKGeorge F. Koob
George F. Koob
LVLeandro F. Vendruscolo
Leandro F. Vendruscolo